Gaming Company PLAYSTUDIOS Executive Reduces Stake Through Scheduled Sales

Rhea-AI Filing Summary

PLAYSTUDIOS General Counsel Joel Agena reported multiple insider transactions in a Form 4 filing:

Key Transaction Details:

• Sold 20,490 Class A Common Stock shares at $1.41 (weighted average) on June 20, 2025
• Sold additional 20,490 shares at $1.40 (weighted average) on June 23, 2025
• Transactions executed under a Rule 10b5-1 trading plan adopted March 12, 2025

Current Holdings After Transactions:

• 218,241 direct Class A Common Stock shares
• 291,668 unvested Restricted Stock Units
• 125,000 Performance Stock Units (2025 performance-based)
• 233,043 Stock Options at various strike prices ($0.90-$1.44)
• 28,040 Earnout Shares (contingent on stock reaching $12.50 and $15.00 thresholds)

Positive

• None.

Negative

• General Counsel Joel Agena sold 40,980 shares through a pre-planned 10b5-1 trading plan at average prices of $1.40-1.41, reducing direct holdings by approximately 16% from 259,221 to 218,241 shares

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Agena Joel

(Last) (First) (Middle)

10150 COVINGTON CROSS DRIVE

(Street)

LAS VEGAS NV 89144

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
PLAYSTUDIOS, Inc. [ MYPS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	General Counsel

3. Date of Earliest Transaction (Month/Day/Year)
06/20/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock								259,221	D
Class A Common Stock	06/20/2025		S(1)		20,490	D	$1.41(2)	238,731	D
Class A Common Stock	06/23/2025		S(1)		20,490	D	$1.4(3)	218,241	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	$0(4)							(5)	(5)	Class A Common Stock	125,000		125,000	D
Restricted Stock Units	$0(4)							(6)	(6)	Class A Common Stock	166,668		166,668	D
Performance Stock Units	$0(7)							(7)	(7)	Class A Common Stock	125,000		125,000	D
Stock Options	$0.9							09/01/2018	09/01/2025	Class A Common Stock	46,609		46,609	D
Stock Options	$1.01							05/01/2020	05/01/2027	Class A Common Stock	93,217		93,217	D
Stock Options	$1.44							01/01/2023	01/01/2029	Class A Common Stock	93,217		93,217	D
Earnout Shares	$0							(8)	06/21/2026	Class A Common Stock	28,040		28,040	D

Explanation of Responses:

1. This transaction was pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 12, 2025. This trading plan was previously disclosed in the Issuer's Quarterly Report on Form 10-Q filed on May 9, 2025.

2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.38 to $1.44 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.39 to $1.43 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

4. Each Restricted Stock Unit represents the contingent right to receive, upon vesting and settlement, one share of Class A Common Stock.

5. On March 7, 2025, the Reporting Person was granted 166,667 unvested Restricted Stock Units. Each Restricted Stock Unit represents the contingent right to receive, upon vesting and settlement, one share of Class A Common Stock. The Restricted Stock Units are scheduled to vest as follows, subject in each case to the Reporting Person's continued employment with the Company through the applicable vesting date: 41,667 Restricted Stock Units vesting on May 15, 2025; 41,667 Restricted Stock Units vesting on January 15, 2026; 41,667 Restricted Stock Units vesting on January 15, 2027; and 41,666 Restricted Stock Units vesting on January 15, 2028.

6. On March 11, 2024, the Reporting Person was granted 358,335 unvested Restricted Stock Units. Each Restricted Stock Unit represents the contingent right to receive, upon vesting and settlement, one share of Class A Common Stock. The Restricted Stock Units are scheduled to vest as follows, subject in each case to the Reporting Person's continued employment with the Company through the applicable vesting date: 66,667 Restricted Stock Units vesting on May 15, 2024; 125,000 Restricted Stock Units vesting on May 15, 2025; 83,334 Restricted Stock Units vesting on May 15, 2026; and 83,334 Restricted Stock Units vesting on May 15, 2027.

7. On March 7, 2025, the Reporting Person was granted 125,000 unvested Performance Stock Units. Each Performance Stock Unit represents the contingent right to receive, upon vesting and settlement, up to one share of Class A Common Stock. The actual number of shares of Class A Common Stock to be issued upon vesting of such Performance Stock Units will be determined based on, and will be contingent upon, the achievement of certain pre-established performance metrics, as determined by the Compensation Committee of the Company's Board of Directors, for the fiscal year ending December 31, 2025.

8. Payable in two equal tranches if the closing price of the Class A Common Stock exceeds $12.50 and $15.00 per share, respectively, for any 20 trading days within any 30-trading day period commencing on or after the 150th day following the closing (the "Closing") of the business combination pursuant to the Agreement and Plan of Merger, dated as of February 1, 2021, by and among Acies Acquisition Corp., Catalyst Merger Sub I, Inc., Catalyst Merger Sub II, LLC, and Old PLAYSTUDIOS, and ending no later than the five-year anniversary of the Closing (the earnout consideration will also vest based on the price targets in connection with a sale of the Issuer).

Remarks:

	/s/ Joel Agena	06/24/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many MYPS shares did General Counsel Joel Agena sell in June 2025?

Joel Agena sold a total of 40,980 shares of MYPS Class A Common Stock in two transactions: 20,490 shares on June 20, 2025, at an average price of $1.41 per share, and another 20,490 shares on June 23, 2025, at an average price of $1.40 per share.

What is Joel Agena's remaining MYPS stock position after the June 2025 sales?

After the reported transactions, Joel Agena directly owns 218,241 shares of MYPS Class A Common Stock. Additionally, he holds various derivative securities including 291,668 Restricted Stock Units, 125,000 Performance Stock Units, 233,043 Stock Options at various strike prices, and 28,040 Earnout Shares.

Were MYPS insider Joel Agena's stock sales planned in advance?

Yes, the sales were made pursuant to a Rule 10b5-1 trading plan that Joel Agena adopted on March 12, 2025. This trading plan was previously disclosed in the company's Quarterly Report filed on May 9, 2025.

What are the vesting terms for MYPS General Counsel's recent RSU grants?

Agena received two recent RSU grants: 1) 166,667 RSUs granted on March 7, 2025, vesting in tranches through January 15, 2028, and 2) 358,335 RSUs granted on March 11, 2024, vesting in tranches through May 15, 2027. Both grants are subject to continued employment with MYPS through the applicable vesting dates.

What performance conditions apply to MYPS executive Joel Agena's PSU grant?

On March 7, 2025, Agena was granted 125,000 Performance Stock Units (PSUs). The actual shares to be issued will be determined based on achievement of pre-established performance metrics for fiscal year 2025, as determined by the MYPS Board's Compensation Committee.